1,474
Views
0
CrossRef citations to date
0
Altmetric
Interview

Interview with Donald E Ingber

Pages 949-954 | Published online: 30 Jun 2014

References

  • Ingber DE , FujitaT, KishimotoSet al. Synthetic analogues of fumagillin which inhibit angiogenesis and suppress tumour growth. Nature348, 555–557 (1990).
  • Korin N , KanapathipillaiM, MatthewBDet al. Shear-activated nanotherapeutics for drug targeting to obstructed blood vessels. Science337, 738–742 (2012).
  • Brock A , KrauseS, LiHet al. Silencing HoxA1 by intraductal injection of siRNA lipidoid nanoparticles prevents mammary tumor progression in mice. Sci. Trans. Med.6 (217), 6:217ra2 (2014).
  • Huh D , MatthewsBD, MammotoA, Montoya-ZavalaM, HsinHY, IngberDE. Reconstituting organ-level lung functions on a chip. Science328, 1662–1668 (2010).
  • Huh D , LeslieDC, MatthewsBDet al. A human disease model of drug toxicity-induced pulmonary edema in a lung-on-a-chip microdevice. Sci. Trans. Med4, 159ra147 (2012).
  • Ingber DE , JamiesonJD. Cells as tensegrity structures: architectural regulation of histodifferentiation by physical forces tranduced over basement membrane. In: Gene Expression During Normal and Malignant Differentiation.AnderssonLC, GahmbergCG, EkblomP (Eds). Academic Press, FL, USA13–32 (1985).
  • Wang N , ButlerJP, IngberD. Mechanotransduction across the cell surface and through the cytoskeleton. Science260 (5111), 1124–1127 (1993).
  • Singhvi R , KumarA, LopezGet al. Engineering cell shape and function. Science264, 696–698 (1994).
  • Chen CS , MrksichM, HuangS, WhitesidesGM, IngberDE. Geometric control of cell life and death. Science276 (5317), 1425–1428 (1997).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.